Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In terms of clinical application, the GPX4 agonist selenomethionine (Se-Met) upregulates GPX4 expression in a liver cancer model, and in combination with a PD-1 antibody, it significantly improves the complete response rate (CR) (183)
Improves Texture: Uneven skin texture and roughness can affect your confidence
Knowing what to watch for and how to respond ensures successful treatment
These findings suggest benefits beyond cancer treatment, such as supporting heart health during chemotherapy, warranting further research into its therapeutic properties
Its effects are localized, making it less effective for systemic antioxidant support but useful for addressing specific skin concerns
Elife 3, e02523 (2014)
US$ 28.53
US$ 23.07
US$ 22.73
US$ 25.27
